Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients. [electronic resource] by
- Malaguarnera, Michele
- Vacante, Marco
- Russo, Cristina
- Gargante, Maria Pia
- Giordano, Maria
- Bertino, Gaetano
- Neri, Sergio
- Malaguarnera, Mariano
- Galvano, Fabio
- Li Volti, Giovanni
Producer: 20111123
In:
Hepatitis monthly vol. 11
Availability: No items available.
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
|